Artificial intelligence-guided detection of under-recognised cardiomyopathies on point-of-care cardiac ultrasonography: a multicentre study

IF 23.8 1区 医学 Q1 MEDICAL INFORMATICS Lancet Digital Health Pub Date : 2025-02-01 DOI:10.1016/S2589-7500(24)00249-8
Evangelos K Oikonomou MD , Akhil Vaid MD , Gregory Holste BA , Andreas Coppi PhD , Robert L McNamara MD , Cristiana Baloescu MD , Harlan M Krumholz MD , Zhangyang Wang PhD , Donald J Apakama MD , Girish N Nadkarni MD , Rohan Khera MD
{"title":"Artificial intelligence-guided detection of under-recognised cardiomyopathies on point-of-care cardiac ultrasonography: a multicentre study","authors":"Evangelos K Oikonomou MD ,&nbsp;Akhil Vaid MD ,&nbsp;Gregory Holste BA ,&nbsp;Andreas Coppi PhD ,&nbsp;Robert L McNamara MD ,&nbsp;Cristiana Baloescu MD ,&nbsp;Harlan M Krumholz MD ,&nbsp;Zhangyang Wang PhD ,&nbsp;Donald J Apakama MD ,&nbsp;Girish N Nadkarni MD ,&nbsp;Rohan Khera MD","doi":"10.1016/S2589-7500(24)00249-8","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Point-of-care ultrasonography (POCUS) enables cardiac imaging at the bedside and in communities but is limited by abbreviated protocols and variation in quality. We aimed to develop and test artificial intelligence (AI) models to screen for under-diagnosed cardiomyopathies from cardiac POCUS.</div></div><div><h3>Methods</h3><div>In a development set of 290 245 transthoracic echocardiographic videos across the Yale–New Haven Health System (YNHHS), we used augmentation approaches, and a customised loss function weighted for view quality to derive a POCUS-adapted, multi-label, video-based convolutional neural network that discriminates hypertrophic cardiomyopathy and transthyretin amyloid cardiomyopathy from controls without known disease. We evaluated the model across independent, internal, and external, retrospective cohorts of individuals undergoing cardiac POCUS across YNHHS and the Mount Sinai Health System (MSHS) emergency departments (between 2012 and 2024) to prioritise key views and validate the diagnostic and prognostic performance of single-view screening protocols.</div></div><div><h3>Findings</h3><div>Between Nov 1, 2023, and March 28, 2024, we identified 33 127 patients (mean age 58·9 [SD 20·5] years, 17 276 [52·2%] were female, 14 923 [45·0%] were male, and for 928 [2·8%] sex was recorded as unknown) at YNHHS and 5624 patients (mean age 56·0 [20·5] years, 1953 [34·7%] were female, 2470 [43·9%] were male, and for 1201 [21·4%] sex was recorded as unknown) at MSHS with 78 054 and 13 796 eligible cardiac POCUS videos, respectively. AI deployed to single-view POCUS videos successfully discriminated hypertrophic cardiomyopathy (eg, area under the receiver operating characteristic curve 0·903 [95% CI 0·795–0·981] in YNHHS; 0·890 [0·839–0·938] in MSHS for apical-4-chamber acquisitions) and transthyretin amyloid cardiomyopathy (0·907 [0·874–0·932] in YNHHS; 0·972 [0·959–0·983] in MSHS for parasternal acquisitions). In YNHHS, 40 (58%) of 69 hypertrophic cardiomyopathy cases and 22 (46%) of 48 transthyretin amyloid cardiomyopathy cases would have had a positive screen by AI-POCUS at a median of 2·1 (IQR 0·9–4·5) years and 1·9 (0·6–3·5) years before diagnosis. Moreover, among 25 261 participants without known cardiomyopathy followed up over a median of 2·8 (1·2–6·4) years, AI-POCUS probabilities in the highest (<em>vs</em> lowest) quintile for hypertrophic cardiomyopathy and transthyretin amyloid cardiomyopathy conferred a 17% (adjusted hazard ratio 1·17, 95% CI 1·06–1·29; p=0·0022) and 32% (1·39, 1·19–1·46; p&lt;0·0001) higher adjusted mortality risk, respectively.</div></div><div><h3>Interpretation</h3><div>We developed and validated an AI framework that enables scalable, opportunistic screening of under-recognised cardiomyopathies through simple POCUS acquisitions.</div></div><div><h3>Funding</h3><div>National Heart, Lung, and Blood Institute, Doris Duke Charitable Foundation, and BridgeBio.</div></div>","PeriodicalId":48534,"journal":{"name":"Lancet Digital Health","volume":"7 2","pages":"Pages e113-e123"},"PeriodicalIF":23.8000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Digital Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589750024002498","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL INFORMATICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Point-of-care ultrasonography (POCUS) enables cardiac imaging at the bedside and in communities but is limited by abbreviated protocols and variation in quality. We aimed to develop and test artificial intelligence (AI) models to screen for under-diagnosed cardiomyopathies from cardiac POCUS.

Methods

In a development set of 290 245 transthoracic echocardiographic videos across the Yale–New Haven Health System (YNHHS), we used augmentation approaches, and a customised loss function weighted for view quality to derive a POCUS-adapted, multi-label, video-based convolutional neural network that discriminates hypertrophic cardiomyopathy and transthyretin amyloid cardiomyopathy from controls without known disease. We evaluated the model across independent, internal, and external, retrospective cohorts of individuals undergoing cardiac POCUS across YNHHS and the Mount Sinai Health System (MSHS) emergency departments (between 2012 and 2024) to prioritise key views and validate the diagnostic and prognostic performance of single-view screening protocols.

Findings

Between Nov 1, 2023, and March 28, 2024, we identified 33 127 patients (mean age 58·9 [SD 20·5] years, 17 276 [52·2%] were female, 14 923 [45·0%] were male, and for 928 [2·8%] sex was recorded as unknown) at YNHHS and 5624 patients (mean age 56·0 [20·5] years, 1953 [34·7%] were female, 2470 [43·9%] were male, and for 1201 [21·4%] sex was recorded as unknown) at MSHS with 78 054 and 13 796 eligible cardiac POCUS videos, respectively. AI deployed to single-view POCUS videos successfully discriminated hypertrophic cardiomyopathy (eg, area under the receiver operating characteristic curve 0·903 [95% CI 0·795–0·981] in YNHHS; 0·890 [0·839–0·938] in MSHS for apical-4-chamber acquisitions) and transthyretin amyloid cardiomyopathy (0·907 [0·874–0·932] in YNHHS; 0·972 [0·959–0·983] in MSHS for parasternal acquisitions). In YNHHS, 40 (58%) of 69 hypertrophic cardiomyopathy cases and 22 (46%) of 48 transthyretin amyloid cardiomyopathy cases would have had a positive screen by AI-POCUS at a median of 2·1 (IQR 0·9–4·5) years and 1·9 (0·6–3·5) years before diagnosis. Moreover, among 25 261 participants without known cardiomyopathy followed up over a median of 2·8 (1·2–6·4) years, AI-POCUS probabilities in the highest (vs lowest) quintile for hypertrophic cardiomyopathy and transthyretin amyloid cardiomyopathy conferred a 17% (adjusted hazard ratio 1·17, 95% CI 1·06–1·29; p=0·0022) and 32% (1·39, 1·19–1·46; p<0·0001) higher adjusted mortality risk, respectively.

Interpretation

We developed and validated an AI framework that enables scalable, opportunistic screening of under-recognised cardiomyopathies through simple POCUS acquisitions.

Funding

National Heart, Lung, and Blood Institute, Doris Duke Charitable Foundation, and BridgeBio.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
41.20
自引率
1.60%
发文量
232
审稿时长
13 weeks
期刊介绍: The Lancet Digital Health publishes important, innovative, and practice-changing research on any topic connected with digital technology in clinical medicine, public health, and global health. The journal’s open access content crosses subject boundaries, building bridges between health professionals and researchers.By bringing together the most important advances in this multidisciplinary field,The Lancet Digital Health is the most prominent publishing venue in digital health. We publish a range of content types including Articles,Review, Comment, and Correspondence, contributing to promoting digital technologies in health practice worldwide.
期刊最新文献
The urgent need to accelerate synthetic data privacy frameworks for medical research From the 100 Day Mission to 100 lines of software development: how to improve early outbreak analytics Prediction of emergency admissions: trade-offs between model simplicity and performance AI for medical diagnosis: does a single negative trial mean it is ineffective? Artificial intelligence-guided detection of under-recognised cardiomyopathies on point-of-care cardiac ultrasonography: a multicentre study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1